FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On August 3, 2007
Docket # Title
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
2005N-0272 Irradiation in the Production, Processing & Handling of Food
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
2006D-0347 Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
2006P-0272 ANDA Suitability for 0.9% Sodium Chloride Injection
2006P-0273 ANDA for Water for Injection, USP, in 3-, 5-, 15-, and 30-mL volumes
2007D-0268 Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Poly(hydroxybutyrate) Surgical Suture Produced by Recombinant DNA Technology
2007N-0267 Medical Devices; General and Plastic Surgery Devices; Classification of Absorbable Poly(hydroxybutyrate) Surgical Suture Produced by Recombinant DNA Technology
2007P-0307 To permit an ANDA Suitability for Hydrocodone Bitartrate and Homatropine Methylbromide Capsules 5 mg / 1.5 mg
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 20465 PURE HEALTHY SCIENCES, LLC Vol #: 179
LET 20466 SILVERIO SALINAS INC. Vol #: 179
LET 20467 PuraPharm Vol #: 179
LET 20468 Ganeden Biotech Inc. Vol #: 179
LET 20469 DHC Vol #: 179
LET 20470 NATROL Vol #: 179
LET 20471 Wyeth Consumer Healthcare Vol #: 179
LET 20472 Enzmatic Therapy Vol #: 179
LET 20473 Enzmatic Therapy Vol #: 179
LET 20474 Enzmatic Therapy Vol #: 179
LET 20475 Enzmatic Therapy Vol #: 179
LET 20476 Enzmatic Therapy Vol #: 179
LET 20477 Enzmatic Therapy Vol #: 179
LET 20478 Enzmatic Therapy Vol #: 179
LET 20479 Enzmatic Therapy Vol #: 179
LET 20480 Enzmatic Therapy Vol #: 179
LET 20481 Enzmatic Therapy Vol #: 179
LET 20482 Enzmatic Therapy Vol #: 179
LET 20483 Enzmatic Therapy Vol #: 179
LET 20484 Enzmatic Therapy Vol #: 179
LET 20485 Enzmatic Therapy Vol #: 179
LET 20486 Enzmatic Therapy Vol #: 179
LET 20487 Enzmatic Therapy Vol #: 179
LET 20488 Enzmatic Therapy Vol #: 179
LET 20489 Enzmatic Therapy Vol #: 179
LET 20490 Enzmatic Therapy Vol #: 179
LET 20491 Enzmatic Therapy Vol #: 179
LET 20492 Enzmatic Therapy Vol #: 179
LET 20493 Enzmatic Therapy Vol #: 179
LET 20494 Enzmatic Therapy Vol #: 179
LET 20495 Enzmatic Therapy Vol #: 179
LET 20496 Enzmatic Therapy Vol #: 179
LET 20497 Metagenics Vol #: 179
LET 20498 Metagenics Vol #: 179
LET 20499 NUTRAGENESIS Vol #: 179
LET 20500 Source Naturals Vol #: 179
LET 20501 Ajinomoto USA, Inc. Vol #: 179
LET 20502 Ajinomoto USA, Inc. Vol #: 179
LET 20503 Ajinomoto USA, Inc. Vol #: 179
LET 20504 BiOTECH CORPORATION Vol #: 179
LET 20505 American Institute of Eastern Medicine Vol #: 179
LET 20506 World Nutrition Vol #: 179
LET 20507 NEUROSCIENCE Vol #: 179
LET 20508 Perrigo Company of South Carolina Vol #: 179
LET 20509 Perrigo Company of South Carolina Vol #: 179
LET 20510 Perrigo Company of South Carolina Vol #: 179
LET 20511 Perrigo Company of South Carolina Vol #: 179
LET 20512 Perrigo Company of South Carolina Vol #: 179
LET 20513 Perrigo Company of South Carolina Vol #: 179
LET 20514 Perrigo Company of South Carolina Vol #: 179
LET 20515 Perrigo Company of South Carolina Vol #: 179
LET 20516 Perrigo Company of South Carolina Vol #: 179
LET 20517 Perrigo Company of South Carolina Vol #: 179
LET 20518 Perrigo Company of South Carolina Vol #: 179
LET 20519 Montana Vita Natural Health LLC Vol #: 179
LET 20520 Robert E. Armstrong Vol #: 179
LET 20521 Perrigo Company of South Carolina Vol #: 179
LET 20522 Perrigo Company of South Carolina Vol #: 179
LET 20523 Randolph Gregg Vol #: 179
LET 20524 DHC Vol #: 179
2005N-0272 Irradiation in the Production, Processing & Handling of Food
C 3204 W. Motta Vol #: 38
C 3205 T. Metz Vol #: 38
C 3206 N. Bonilla Vol #: 38
C 3207 J. Ditton Vol #: 38
C 3208 L. Benigni Vol #: 38
C 3209 W. Soloman Vol #: 38
C 3210 M. Bottesch Vol #: 38
C 3211 M. W. Coleman Vol #: 38
C 3212 K. Bradford Vol #: 38
C 3213 E. M. Reid Vol #: 38
C 3214 G. Jones Vol #: 38
C 3215 S. Jaworski Vol #: 38
C 3216 D. M. Lugo Vol #: 38
C 3217 A. M. Adiletta Vol #: 38
C 3218 D. Gotthardt Vol #: 38
C 3219 P. Steedley Vol #: 38
C 3220 A. Ryan Vol #: 38
C 3221 J. Russo Vol #: 38
C 3222 O. Hernandez Vol #: 38
C 3223 M. Henry Vol #: 38
C 3224 T. Miller Vol #: 38
C 3225 C. Morris Vol #: 38
C 3226 R. M. Vol #: 38
C 3227 M. Pedersen Vol #: 38
C 3228 S. Hanlin Vol #: 38
C 3229 J. Hansen Vol #: 38
C 3230 T. Sparenborg Vol #: 38
C 3231 M. Simpson Vol #: 38
C 3232 J. Peck Vol #: 38
C 3233 P. A. Einbond Vol #: 38
C 3234 N. Abram Vol #: 38
C 3235 R. Legge Vol #: 38
C 3236 J. Zack Vol #: 38
C 3237 B. Caulfield Vol #: 38
C 3238 E. Capouano Vol #: 38
C 3239 M. Cooley Vol #: 38
C 3240 P. Eskow Vol #: 38
C 3241 J. Roberts Vol #: 38
C 3242 J. Erlanger Vol #: 38
C 3243 E. M. Conrad Vol #: 38
C 3244 J. Son Vol #: 38
C 3245 M. Murphy Vol #: 38
C 3246 K. Cool Vol #: 38
C 3247 D. M. Bombard Vol #: 38
C 3248 M. Bowen Vol #: 38
C 3249 O. V. Tetkowski Vol #: 38
C 3250 L. Greenawalt Vol #: 38
C 3251 G. Cool Vol #: 38
C 3252 R. Macdonlad Vol #: 38
C 3253 C. Kingery Vol #: 38
C 3254 M. Adams Vol #: 38
C 3255 L. Truitt Vol #: 38
C 3256 C. Barton Vol #: 38
C 3257 S. Porpora Vol #: 38
C 3258 M. Verhelle Vol #: 38
C 3259 M. Zaborek Vol #: 38
C 3260 C. Demartini Vol #: 38
C 3261 R. Barbu Vol #: 38
C 3262 S. M. Anderson Vol #: 38
C 3263 S. Warrow Vol #: 38
C 3264 G. Lennstrom Vol #: 38
C 3265 D. Evans Vol #: 38
C 3266 L. Mazer Vol #: 38
C 3267 R. Kay Vol #: 38
C 3268 J. Schwarz Vol #: 38
C 3269 N. Alvarez Vol #: 38
C 3270 S. Frye Vol #: 38
C 3271 D. Bryan Vol #: 38
C 3272 K. Storie Vol #: 38
C 3273 C. Perkins Vol #: 38
C 3274 J. Almli Vol #: 38
C 3275 M. Fanning Vol #: 38
C 3276 K. Schrader Vol #: 38
C 3277 L. Frey Vol #: 38
C 3278 G. And L. Rose Blume Vol #: 38
C 3279 S. Reding Vol #: 38
C 3280 T. Mcfadden Vol #: 38
C 3281 S. Bodow Vol #: 38
C 3282 B. F. Lawton Vol #: 38
C 3283 A. Carrel Vol #: 38
C 3284 R. Linn Vol #: 38
C 3285 P. Pendley Vol #: 38
C 3286 A. Pennell Vol #: 38
C 3287 P. Prentice-best Vol #: 38
C 3288 T. Paquette Vol #: 38
C 3289 M. Benoit Vol #: 38
C 3290 W. E. Warsi Vol #: 38
C 3291 S. Millerman Vol #: 38
C 3292 K. Schmitt Vol #: 38
C 3293 A. Gasparre Vol #: 38
C 3294 D. Pawluczyk Vol #: 38
C 3295 C. Lefemine Vol #: 38
C 3296 J. Richter Vol #: 38
C 3297 P. Haardesty Vol #: 38
C 3298 L. Wilson Vol #: 38
C 3299 R. Benedict Vol #: 38
C 3300 M. J. Mcgee Vol #: 38
C 3301 B. Yuspa Vol #: 38
C 3302 K. Jurson Vol #: 38
C 3303 G. Picchetti Vol #: 38
C 3304 D. Hall Vol #: 38
C 3305 K. Hurschik Vol #: 38
C 3306 M. Barlow Vol #: 38
C 3307 J. O'brien Vol #: 38
C 3308 D. Ruvo Vol #: 39
C 3309 M. C. Reid Vol #: 39
C 3310 B. Boyle Vol #: 39
C 3311 M. Tabatcher Vol #: 38
C 3312 J. Biss Vol #: 39
C 3313 J. M. Ferguson Vol #: 39
C 3314 C. Stallard Vol #: 39
C 3315 J. Schweizer Vol #: 39
C 3316 J. Treichel Vol #: 39
C 3317 D. Cera Vol #: 39
C 3318 J. E. Long Vol #: 39
C 3319 C. Cullen Vol #: 39
C 3320 M. Weaver Vol #: 39
C 3321 B. Eisenberg Vol #: 39
C 3322 S. Lennox Vol #: 39
C 3323 J. Lange Vol #: 39
C 3324 M. Hughes Vol #: 39
C 3325 A. B. Smith Vol #: 39
C 3326 S. Harris Vol #: 39
C 3327 J. Ball Vol #: 39
C 3328 O. Selfridge Vol #: 39
C 3329 R. Craig Vol #: 39
C 3330 S. Mccarthy Vol #: 39
C 3331 M. Nigro Vol #: 39
C 3332 C. Heuman Vol #: 39
C 3333 C. Cox Vol #: 39
C 3334 M. Johannsen Vol #: 39
C 3335 W. Nichols Vol #: 39
C 3336 R. Minniss Vol #: 39
C 3337 H. Ortmann Vol #: 39
C 3338 E. Obregon Vol #: 39
C 3339 S. Savidge Vol #: 39
C 3340 M. Carlucci Vol #: 39
C 3341 E. B. Duff Vol #: 39
C 3342 T. Barnes Vol #: 39
C 3343 C. Greco Vol #: 39
C 3344 C. Partington Vol #: 39
C 3345 S. Harper Vol #: 39
C 3346 A. L.garson Vol #: 38
C 3347 R. Piriano Vol #: 39
C 3348 L. Oostendorp Vol #: 39
C 3349 J. Mc Carty Vol #: 39
C 3350 E. Caplan Vol #: 39
C 3351 D. Seymour Vol #: 39
C 3352 J. Burroughs Vol #: 39
C 3353 V. Harvey Vol #: 39
C 3354 D. Delosa Vol #: 39
C 3355 J. Thacker Vol #: 39
C 3356 M. Mitchell Vol #: 39
C 3357 B. Heffner Vol #: 39
C 3358 P. R. Walsh Vol #: 39
C 3359 J. Rella Vol #: 39
C 3360 S. Heiss Vol #: 39
C 3361 A. Krok Vol #: 39
C 3362 P. Hendricks Vol #: 39
C 3363 D. Oden Vol #: 39
C 3364 A. Albright Vol #: 39
C 3365 K. Horton Vol #: 39
C 3366 K. Alcaide Vol #: 39
C 3367 S. & J.Dickerman Vol #: 39
C 3368 D. White Vol #: 39
C 3369 S. Cafarelli Vol #: 39
C 3370 S. Fremont Vol #: 39
C 3371 B. White Vol #: 39
C 3372 R. Nestler Vol #: 39
C 3373 M. Cole Vol #: 39
C 3374 D. Paton Vol #: 39
C 3375 G. Wright Vol #: 39
C 3376 A. Mcgee Vol #: 39
C 3377 P. D. Aglione Vol #: 39
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
C 18332 L. Hales Vol #: 198
2006D-0347 Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
EC 88 Longwell and Associates Vol #: 2
LET 1 FDA to Personalized Medicine Coalition Vol #: 3
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
C 24 Inez McMahan Vol #: 1
C 25 Donna Lee Vol #: 1
C 26 Mrs Elizabeth (Betty) G. Creager Vol #: 1
C 27 Honeywell Vol #: 1
C 28 Form Letter Count 1438 Vol #: 5
C 29 J. Batson Vol #: 1
C 30 R. Sherman Vol #: 1
C 31 J. Gusher Vol #: 1
C 32 A. Wood Vol #: 1
C 33 H. Tucker Vol #: 1
C 34 G. Teal Vol #: 1
C 35 J. Winters Vol #: 1
C 36 N. Blankenbiller Vol #: 1
C 37 H. Newell Vol #: 1
C 38 D. Riedl Vol #: 1
C 39 C. Munson Vol #: 1
C 40 C. Dooley Vol #: 1
C 41 A. Backest Vol #: 1
C 42 I. Tanksley Vol #: 1
C 43 E. J O'Brien Vol #: 1
C 44 W. Warrick Sr` Vol #: 1
C 45 R. D. Draper Vol #: 1
C 46 J. Sullivan Vol #: 1
C 47 T. Beene Vol #: 1
C 48 V. Ruder Vol #: 1
C 49 D. Hunt Vol #: 1
C 50 C. Kenyon Vol #: 1
C 51 B. Bouley Vol #: 1
C 52 R. Hudelson Vol #: 1
C 53 M. Wall Vol #: 1
C 54 H. G. Huddleston Vol #: 1
C 55 R. Obermeyer Vol #: 1
C 56 B. Benedict Vol #: 1
C 57 R. J. Zajac Vol #: 1
C 58 A. Kusala Vol #: 1
C 59 P. Monaghan Vol #: 1
C 60 E. Strouse Vol #: 1
C 61 D. Koch Vol #: 1
C 62 M. Moran Vol #: 1
C 63 C. Knazik Vol #: 1
C 64 A. L. Lombardi Vol #: 1
C 65 A. Neri Vol #: 1
C 66 E. Morichelli Vol #: 1
C 67 S. Cook Vol #: 1
C 68 E. Matters Vol #: 1
C 69 M. Pierce Vol #: 1
C 70 A. Halpern Vol #: 1
C 71 D. McGraw Vol #: 1
C 72 Y. Honditch Vol #: 1
C 73 L. Amey Vol #: 1
C 74 I. Fischbein Vol #: 1
C 75 L. D. Nacchio Vol #: 1
C 76 M. Mundy Vol #: 1
C 77 R. Angelo Vol #: 1
C 78 L. Eaton Vol #: 1
C 79 E. Smith Vol #: 1
C 80 L. Reider Vol #: 1
C 81 P. Capilo Vol #: 1
C 82 M. Coletta Vol #: 1
C 83 B. Winstead Vol #: 1
C 84 S. Mom Vol #: 1
C 85 J. McElvein Vol #: 1
C 86 J. Terrell Vol #: 1
C 87 P. Grossi Vol #: 1
C 88 O. Cranfield Vol #: 1
C 89 V. Cayen Vol #: 1
C 90 E. Rodeschia Vol #: 1
C 91 G. Hinson Vol #: 1
C 92 E. Norman Vol #: 1
C 93 E. S. Briscoe Vol #: 1
C 94 M. Link Vol #: 1
C 95 R. Settino Vol #: 1
C 96 V. Kocsis Vol #: 1
C 97 D. Burrows Vol #: 1
C 98 R. Sherod Vol #: 1
C 99 B. J. Whitsitt Vol #: 1
C 100 J. Fleharty Vol #: 1
C 101 A. Beebe Vol #: 1
C 102 V. Moore Vol #: 1
C 103 J. Fielder Vol #: 1
C 104 E. Mcknight Vol #: 1
2006P-0272 ANDA Suitability for 0.9% Sodium Chloride Injection
LET 1 Catalent Vol #: 1
2006P-0273 ANDA for Water for Injection, USP, in 3-, 5-, 15-, and 30-mL volumes
LET 1 Catalent Vol #: 1
2007D-0268 Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Poly(hydroxybutyrate) Surgical Suture Produced by Recombinant DNA Technology
GDL 1 Guidance Vol #: 1
NAD 1 FDA Vol #: 1
2007N-0267 Medical Devices; General and Plastic Surgery Devices; Classification of Absorbable Poly(hydroxybutyrate) Surgical Suture Produced by Recombinant DNA Technology
NFR 1 FDA Vol #: 1
2007P-0307 To permit an ANDA Suitability for Hydrocodone Bitartrate and Homatropine Methylbromide Capsules 5 mg / 1.5 mg
ACK 1 Lachman Consultant Services, Inc. Vol #: 1
CP 1 Lachman Consultant Services, Inc. Vol #: 1

Page created on August 3, 2007 ue

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management